As of March 10, 2024, this course is no longer open for enrollment

As of March 10, 2024, this course is no longer open for enrollment


Continuing Education Credits

Course meets the requirements for 1 RACE hours of continuing education credit for veterinary technicians and veterinarians in jurisdictions which recognize AAVSB's RACE approval. However, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery.

RACE Subject Category: Medical; Delivery Method: Non-interactive Distance; Program Number 1024948.


Content Presenter

Todd Cohen, DVM, DACVIM (Small Animal Internal Medicine)


Course Focus and Learning Objectives

How the “blood test for cancer” performs in the real world: An analysis of 1,500 liquid biopsy cases is a free veterinary CE offering made possible through the generous educational support of PetDx®.

This course utilizes the archive of a live presentation.

Blood-based liquid biopsy using next-generation sequencing (NGS) became clinically available in May 2021. Since that time, the test has been ordered for thousands of patients, primarily as a screening tool for dogs at higher risk of cancer as well as an aid in diagnosis for dogs for which there is a clinical suspicion of cancer.

This course reviews data from a recent publication in the Journal of the American Veterinary Medical Association (JAVMA) analyzing a cohort of 1,500 consecutive liquid biopsy tests received for commercial testing at one clinical laboratory. It includes a discussion of ordering patterns, positivity rates, and patient outcome data, along with how this data can be used to discuss liquid biopsy testing with clients. A series of interesting case studies are presented, exploring the use of this testing in a variety of clinical settings.

After completion of this course, the student should be able to:

  • explain how next-generation sequencing technology can be used to identify cancer in dogs using a simple blood draw
  • examine liquid biopsy performance in a cohort of 1,500 consecutive samples submitted for commercial testing
  • outline how to use this data to explain liquid biopsy testing to clients
  • Explore the use of liquid biopsy testing in clinical practice through a series of interesting case studies


Open Enrollment with Immediate Access and Individual Scheduling

This is an open enrollment course. Participants may enroll at any time. Upon submission of enrollment the participant is immediately added to the course. The course welcome email provides login and other important information.

This is an asynchronous course, meaning it does not contain real time components. Participants do not need to be logged into the course at specific times to attend lectures or view presentations.

Participants do not need to complete the course in one sitting. However, students who do not access the course within 30 days of last access will be processed as incomplete. Any activity within the course will reset to the full 30 days time allotment.

Participants who are unable to complete a course may re-enroll at their convenience providing the course is still available.


Completion Requirements

The completion requirements for this course are:

  • complete the examination with a score of 80% or better - multiple attempts are permitted
  • submit the course survey

Upon submission of the final completion requirement, the participant will automatically be marked as completed and the course completion email will be sent out. The participant will have immediate access to the certificate.


Course Fee

Price: FREE